EGF Theramed Health Corp.
TMED
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | 2.30K | 2.30K |
| Gross Profit | -- | -- | -- | -2.30K | -2.30K |
| SG&A Expenses | 179.90K | 187.80K | 188.70K | 173.60K | 167.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 179.90K | 187.80K | 188.70K | 175.90K | 169.90K |
| Operating Income | -179.90K | -187.80K | -188.70K | -175.90K | -169.90K |
| Income Before Tax | -1.64M | -1.74M | -1.73M | -316.90K | -319.50K |
| Income Tax Expenses | 598.20K | 601.30K | 601.30K | 3.10K | 3.10K |
| Earnings from Continuing Operations | -2.24 | -2.35 | -2.33 | -0.32 | -0.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 10.70K | 23.90K | 16.50K | 26.00K | 29.80K |
| Net Income | -2.23M | -2.32M | -2.31M | -294.00K | -292.80K |
| EBIT | -179.90K | -187.80K | -188.70K | -175.90K | -169.90K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.19 | -0.20 | -0.20 | -0.03 | -0.03 |
| Normalized Basic EPS | -0.09 | -0.09 | -0.09 | -0.01 | -0.01 |
| EPS Diluted | -0.19 | -0.20 | -0.20 | -0.03 | -0.03 |
| Normalized Diluted EPS | -0.09 | -0.09 | -0.09 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 46.47M | 46.47M | 46.39M | 46.16M | 45.93M |
| Average Diluted Shares Outstanding | 46.47M | 46.47M | 46.39M | 46.16M | 45.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |